Table 3.

Macular pigment optical density (MPOD) response to placebo. See Table 2 for details.

Subject/eye	MPOD pre AU	SD pre AU	Rate of change in MPOD ± SE, mAU/day	p	Significance of rate of change
11/L	0.244	0.034	0.01 ± 0.43	0.99	No signif. change
11/R	0.246	0.055	-0.20 ± 0.26	0.46	No signif. change
12/L	0.570	0.043	-0.99 ± 0.23	0.0001	Signif. decrease
12/R	0.551	0.105	-0.10 ± 0.22	0.65	No signif. change
13/L	0.473	0.065	0.00 ± 0.30	0.99	No signif. change
13/R	0.397	0.077	0.66 ± 0.41	0.12	No signif. change
14/L	0.825	0.067	0.03 ± 0.94	0.98	No signif. change
14/R	0.922	0.186	0.36 ± 0.33	0.30	No signif. change
15/L	0.328	0.050	0.14 ± 0.22	0.53	No signif. change
15/R	0.334	0.058	-0.11 ± 0.24	0.66	No signif. change
16/L	0.492	0.048	-0.72 ± 0.16	<0.0001	Signif. decrease
16/R	0.527	0.022	-0.60 ± 0.18	0.0020	Signif. decrease
17/L	0.579	0.036	-0.64 ± 0.87	0.48	No signif. change
17/R	0.482	0.054	-0.32 ± 0.49	0.52	No signif. change
18/L	0.628	0.041	-0.28 ± 0.30	0.36	No signif. change
18/R	0.625	0.057	0.43 ± 0.28	0.13	No signif. change
19/L	0.739	0.143	-0.44 ± 0.33	0.19	No signif. change
19/R	0.693	0.076	-0.30 ± 0.36	0.41	No signif. change